BEND2
gene geneOn this page
Also known as MGC33653
Summary
BEND2 (BEN domain containing 2, HGNC:28509) is a protein-coding gene on chromosome Xp22.13, encoding BEN domain-containing protein 2 (Q8NDZ0).
This gene encodes a protein which has two BEN domains in the C-terminus. These domains are found in proteins which participate in protein and DNA interactions which occur during chromatin restructuring or transcription. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 139105 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 145 total — 1 pathogenic, 1 likely-pathogenic
- MANE Select transcript:
NM_153346
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28509 |
| Approved symbol | BEND2 |
| Name | BEN domain containing 2 |
| Location | Xp22.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC33653 |
| Ensembl gene | ENSG00000177324 |
| Ensembl biotype | protein_coding |
| OMIM | 301150 |
| Entrez | 139105 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000380030, ENST00000380033
RefSeq mRNA: 2 — MANE Select: NM_153346
NM_001184767, NM_153346
CCDS: CCDS14184, CCDS55375
Canonical transcript exons
ENST00000380033 — 14 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001275419 | 18180510 | 18180650 |
| ENSE00001275427 | 18213774 | 18213911 |
| ENSE00001275440 | 18171001 | 18171204 |
| ENSE00001275447 | 18174030 | 18174258 |
| ENSE00001275456 | 18175972 | 18176093 |
| ENSE00001275464 | 18177569 | 18177769 |
| ENSE00001275477 | 18191001 | 18191108 |
| ENSE00001275482 | 18195296 | 18195442 |
| ENSE00001275491 | 18201815 | 18201940 |
| ENSE00001275496 | 18203501 | 18203915 |
| ENSE00001275501 | 18212565 | 18212680 |
| ENSE00001275532 | 18216521 | 18216733 |
| ENSE00001483489 | 18162931 | 18165223 |
| ENSE00001910301 | 18220726 | 18220886 |
Expression profiles
Bgee: expression breadth broad, 30 present calls, max score 86.19.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0201 / max 21.6521, expressed in 3 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 198587 | 0.0102 | 3 |
| 198586 | 0.0099 | 3 |
Top tissues by expression
210 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| monocyte | CL:0000576 | 86.19 | gold quality |
| leukocyte | CL:0000738 | 84.66 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.18 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 65.56 | gold quality |
| blood | UBERON:0000178 | 64.40 | gold quality |
| right testis | UBERON:0004534 | 63.41 | gold quality |
| testis | UBERON:0000473 | 63.19 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 62.88 | gold quality |
| left testis | UBERON:0004533 | 60.91 | gold quality |
| granulocyte | CL:0000094 | 60.89 | gold quality |
| lower lobe of lung | UBERON:0008949 | 59.86 | silver quality |
| superficial temporal artery | UBERON:0001614 | 59.27 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 58.69 | silver quality |
| epithelium of nasopharynx | UBERON:0001951 | 57.97 | gold quality |
| bone marrow cell | CL:0002092 | 57.28 | gold quality |
| bone marrow | UBERON:0002371 | 55.47 | silver quality |
| amniotic fluid | UBERON:0000173 | 55.15 | gold quality |
| myocardium | UBERON:0002349 | 55.09 | gold quality |
| sperm | CL:0000019 | 54.84 | gold quality |
| oocyte | CL:0000023 | 54.62 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 53.31 | gold quality |
| cartilage tissue | UBERON:0002418 | 53.21 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 53.05 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 51.80 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 51.69 | gold quality |
| gingival epithelium | UBERON:0001949 | 51.47 | gold quality |
| caput epididymis | UBERON:0004358 | 51.29 | gold quality |
| adult organism | UBERON:0007023 | 50.51 | gold quality |
| corpus epididymis | UBERON:0004359 | 49.99 | gold quality |
| cauda epididymis | UBERON:0004360 | 49.49 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.23 |
| E-ENAD-27 | no | 15.55 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
73 targeting BEND2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-MIR-3682-5P | 99.93 | 67.97 | 1163 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-380-3P | 99.89 | 70.18 | 1978 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-5003-3P | 99.85 | 69.29 | 2517 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-4799-5P | 99.82 | 70.60 | 2663 |
| HSA-MIR-6885-3P | 99.75 | 70.36 | 3187 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-1283 | 99.69 | 72.42 | 3009 |
| HSA-MIR-4690-5P | 99.65 | 66.24 | 813 |
Literature-anchored findings (GeneRIF, showing 3)
- Spinal cord astroblastoma with an EWSR1-BEND2 fusion classified as a high-grade neuroepithelial tumour with MN1 alteration. (PMID:31863478)
- EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma. (PMID:34825267)
- Early ependymal tumor with MN1-BEND2 fusion: a mostly cerebral tumor of female children with a good prognosis that is distinct from classical astroblastoma. (PMID:36604386)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | selenon | ENSDARG00000033616 |
| danio_rerio | zgc:113423 | ENSDARG00000058978 |
| mus_musculus | Bend2 | ENSMUSG00000108981 |
| rattus_norvegicus | AABR07037896.1 | ENSRNOG00000058952 |
Paralogs (2): SELENON (ENSG00000162430), HOATZ (ENSG00000183644)
Protein
Protein identifiers
BEN domain-containing protein 2 — Q8NDZ0 (reviewed: Q8NDZ0)
All UniProt accessions (1): Q8NDZ0
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NDZ0-1 | 1 | yes |
| Q8NDZ0-2 | 2 |
RefSeq proteins (2): NP_001171696, NP_699177* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR018379 | BEN_domain | Domain |
Pfam: PF10523
UniProt features (16 total): region of interest 4, compositionally biased region 3, domain 2, splice variant 2, sequence variant 2, sequence conflict 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NDZ0-F1 | 49.94 | 0.16 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 31 (showing top):
chrXp22, ZNF146_TARGET_GENES, ZNF8_TARGET_GENES, MIR340_5P, MIR656_3P, MIR3910, MIR5003_3P, MIR450A_1_3P, MIR7113_5P, MIR371A_5P, MIR513B_3P, MIR190B_3P, MIR4468, MIR5587_5P, MIR141_5P
GO Biological Process (0):
GO Molecular Function (2): DNA binding (GO:0003677), protein binding (GO:0005515)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| nucleic acid binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
484 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| BEND2 | MN1 | Q10571 | 687 |
| BEND2 | BANP | Q8N9N5 | 570 |
| BEND2 | BEND4 | Q6ZU67 | 530 |
| BEND2 | BEND5 | Q7L4P6 | 507 |
| BEND2 | CXXC5 | Q7LFL8 | 448 |
| BEND2 | BEND6 | Q5SZJ8 | 433 |
| BEND2 | MAGEB17 | A8MXT2 | 429 |
| BEND2 | ZNF195 | O14628 | 407 |
| BEND2 | ZNF850 | A8MQ14 | 403 |
| BEND2 | NEK4 | P51957 | 400 |
| BEND2 | ZNF394 | Q53GI3 | 398 |
| BEND2 | RAI2 | Q9Y5P3 | 398 |
| BEND2 | ZFTA | C9JLR9 | 397 |
| BEND2 | EWSR1 | Q01844 | 394 |
| BEND2 | CMC2 | Q9NRP2 | 371 |
IntAct
21 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| BEND2 | ANAPC11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BEND2 | ZMYM6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ANAPC11 | BEND2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRR20D | BEND2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SF3A2 | BEND2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LHX2 | BEND2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZMYM6 | BEND2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BEND2 | ECE1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ECE1 | BEND2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ATG16L1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| BEND2 | PRR20D | psi-mi:“MI:0915”(physical association) | 0.000 |
| BEND2 | SF3A2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| BEND2 | LHX2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| BEND2 | ATXN1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (11): BEND2 (Two-hybrid), BEND2 (Two-hybrid), BEND2 (Two-hybrid), BEND2 (Two-hybrid), PRR20B (Two-hybrid), PRR20A (Two-hybrid), PRR20D (Two-hybrid), PRR20C (Two-hybrid), PRR20E (Two-hybrid), BEND2 (Two-hybrid), APP (Reconstituted Complex)
ESM2 similar proteins: A0A1B0GTS1, A0A1B0GWH4, A1A4L6, A1YGI6, A6NDR6, B8QB46, F1MJR8, F1QDF8, O35892, O35893, P09015, P15036, P15037, P23497, P52729, P59598, Q32NH9, Q3KRF1, Q3UM89, Q4G112, Q4V7E1, Q5M7N6, Q5ND04, Q5XIV2, Q5ZHX5, Q66IG8, Q6P1R3, Q6PCX9, Q6PJQ5, Q708W2, Q76I76, Q76I79, Q76N89, Q7M6U3, Q8AXQ4, Q8BVK9, Q8IUE0, Q8IUE1, Q8IWB6, Q8IXJ9
Diamond homologs: A0A096LPI5, A6NIU2, A6NJG6, F2Z398, P0DTE4, P51957, Q09FC8, Q5H9K5, Q5T7P6, Q68CZ1, Q6B4Z3, Q6UX73, Q86U02, Q8IV13, Q8N7M2, Q8N9N2, Q8NDZ0, Q8NEM8, Q8TDM0, Q92918, Q96J02, Q96MD7, Q9BUA6, Q9NXG0, O14607, O14628, O15054, O15550, O70546, P79457, Q5NCY0, Q8N769, A7MCS3, Q3UST5, Q3ZCU0, Q8IUI4, Q08DX0, Q8TEQ0, Q9D3S3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
145 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 1 |
| Uncertain significance | 73 |
| Likely benign | 17 |
| Benign | 5 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 584356 | NC_000023.10:g.(?17393861)(18671684_?)del | Pathogenic |
| 2685694 | GRCh37/hg19 Xp22.13(chrX:18235875-18523090)x1 | Likely pathogenic |
SpliceAI
2683 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:18171016:T:C | donor_gain | 1.0000 |
| X:18171071:TTGG:T | donor_gain | 1.0000 |
| X:18171201:TAGC:T | acceptor_gain | 1.0000 |
| X:18171202:AGCCT:A | acceptor_loss | 1.0000 |
| X:18171204:CCTAG:C | acceptor_loss | 1.0000 |
| X:18171205:C:CA | acceptor_loss | 1.0000 |
| X:18171205:C:CC | acceptor_gain | 1.0000 |
| X:18171206:T:A | acceptor_loss | 1.0000 |
| X:18174023:AACT:A | donor_loss | 1.0000 |
| X:18174028:A:AC | donor_gain | 1.0000 |
| X:18174028:ACT:A | donor_gain | 1.0000 |
| X:18174028:ACTC:A | donor_gain | 1.0000 |
| X:18174029:C:CC | donor_gain | 1.0000 |
| X:18174029:CT:C | donor_gain | 1.0000 |
| X:18174029:CTC:C | donor_gain | 1.0000 |
| X:18174029:CTCC:C | donor_gain | 1.0000 |
| X:18174029:CTCCA:C | donor_gain | 1.0000 |
| X:18174031:C:CA | donor_gain | 1.0000 |
| X:18174262:T:TC | acceptor_gain | 1.0000 |
| X:18175970:A:AC | donor_gain | 1.0000 |
| X:18175971:C:CT | donor_gain | 1.0000 |
| X:18176090:TATT:T | acceptor_gain | 1.0000 |
| X:18177564:CATA:C | donor_loss | 1.0000 |
| X:18177565:ATACC:A | donor_loss | 1.0000 |
| X:18177566:TACC:T | donor_loss | 1.0000 |
| X:18177568:C:CT | donor_loss | 1.0000 |
| X:18177568:CCT:C | donor_gain | 1.0000 |
| X:18177766:TAGC:T | acceptor_gain | 1.0000 |
| X:18177767:AGC:A | acceptor_gain | 1.0000 |
| X:18177768:GC:G | acceptor_gain | 1.0000 |
AlphaMissense
5281 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:18165168:C:A | W747C | 0.998 |
| X:18165168:C:G | W747C | 0.998 |
| X:18165170:A:G | W747R | 0.996 |
| X:18165170:A:T | W747R | 0.996 |
| X:18171092:G:C | F698L | 0.995 |
| X:18171092:G:T | F698L | 0.995 |
| X:18171094:A:G | F698L | 0.995 |
| X:18165217:A:G | L731P | 0.993 |
| X:18165169:C:G | W747S | 0.992 |
| X:18165219:G:C | F730L | 0.991 |
| X:18165219:G:T | F730L | 0.991 |
| X:18165221:A:G | F730L | 0.991 |
| X:18171108:A:G | L693P | 0.991 |
| X:18171117:G:T | A690D | 0.990 |
| X:18171006:A:G | L727P | 0.989 |
| X:18176038:C:A | W562C | 0.988 |
| X:18176038:C:G | W562C | 0.988 |
| X:18171182:T:A | R668S | 0.987 |
| X:18171182:T:G | R668S | 0.987 |
| X:18176087:A:G | L546P | 0.987 |
| X:18171030:A:T | L719H | 0.986 |
| X:18171003:C:G | R728P | 0.985 |
| X:18171096:A:G | L697P | 0.985 |
| X:18171093:A:G | F698S | 0.984 |
| X:18171118:C:G | A690P | 0.984 |
| X:18171195:C:T | G664E | 0.984 |
| X:18176040:A:G | W562R | 0.984 |
| X:18176040:A:T | W562R | 0.984 |
| X:18171009:G:T | A726D | 0.983 |
| X:18171057:C:A | G710V | 0.983 |
dbSNP variants (sampled 300 via entrez): RS1000120610 (X:18211893 T>C,G), RS1000181111 (X:18202044 C>A), RS1000184859 (X:18186949 A>G), RS1000189734 (X:18164695 T>C), RS1000247783 (X:18174744 C>T), RS1000345371 (X:18214156 G>A), RS1000457704 (X:18207508 A>G), RS1000487340 (X:18207192 C>T), RS1000522482 (X:18190197 A>G), RS1000627341 (X:18217887 C>T), RS1000643124 (X:18217239 T>C), RS1000783994 (X:18216635 T>C), RS1000844960 (X:18168330 T>C), RS1000919560 (X:18205402 A>G), RS1000963918 (X:18189236 G>C)
Disease associations
OMIM: gene MIM:301150 | disease phenotypes: MIM:300672
GenCC curated gene-disease
Mondo (1): developmental and epileptic encephalopathy, 2 (MONDO:0010396)
Orphanet (3): Early infantile developmental and epileptic encephalopathy (Orphanet:1934), West syndrome (Orphanet:3451), CDKL5-deficiency disorder (Orphanet:505652)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C564064 | CDKL5 deficiency disorder (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases methylation, increases methylation | 2 |
| triphenyl phosphate | affects expression | 1 |
| Air Pollutants, Occupational | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Nickel | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): developmental and epileptic encephalopathy, 2